Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

MRK

Merck & Co Inc

Feb 06 • 04:00PM ET

88.05

Dollar change -1.62
Percentage change -1.81	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE JNJ ABBV BMY AMGN LLY REGN GILD VRTX BHC

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM IWF VHT

Scroll to Statements

Index	DJIA, S&P 500	P/E	13.08	EPS (ttm)	6.73	Insider Own	0.11%	Shs Outstand	2.53B	Perf Week	-11.02%
Market Cap	222.73B	Forward P/E	8.95	EPS next Y	9.84	Insider Trans	0.00%	Shs Float	2.53B	Perf Month	-11.70%
Income	17.12B	PEG	1.09	EPS next Q	2.14	Inst Own	79.17%	Short Float	1.35%	Perf Quarter	-13.57%
Sales	64.30B	P/S	3.46	EPS this Y	18.33%	Inst Trans	-0.40%	Short Ratio	2.72	Perf Half Y	-20.78%
Book/sh	17.58	P/B	5.01	EPS next Y	8.67%	ROA	10.83%	Short Interest	34.12M	Perf Year	-30.22%
Cash/sh	5.79	P/C	15.22	EPS next 5Y	11.98%	ROE	28.33%	52W Range	87.33 - 134.63	Perf YTD	-11.49%
Dividend Est.	3.34 (3.79%)	P/FCF	15.01	EPS past 5Y	12.04%	ROI	21.54%	52W High	-34.60%	Beta	0.36
Dividend TTM	3.12 (3.54%)	Quick Ratio	1.15	Sales past 5Y	7.21%	Gross Margin	80.65%	52W Low	0.82%	ATR (14)	2.63
Dividend Ex-Date	Mar 17, 2025	Current Ratio	1.36	EPS Y/Y TTM	163.70%	Oper. Margin	33.71%	RSI (14)	27.66	Volatility	2.65% 2.22%
Employees	72000	Debt/Eq	0.86	Sales Y/Y TTM	7.41%	Profit Margin	26.62%	Recom	1.79	Target Price	117.25
Option/Short	Yes / Yes	LT Debt/Eq	0.79	EPS Q/Q	404.83%	Payout	46.32%	Rel Volume	1.54	Prev Close	89.67
Sales Surprise	0.91%	EPS Surprise	6.88%	Sales Q/Q	9.93%	Earnings	Feb 04 BMO	Avg Volume	12.54M	Price	88.05
SMA20	-9.33%	SMA50	-11.21%	SMA200	-22.60%	Trades		Volume	19,308,530	Change	-1.81%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130
Mar-28-23	Downgrade	Societe Generale	Buy → Hold
Mar-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $115
Mar-06-23	Initiated	Jefferies	Buy	$125
Feb-22-23	Upgrade	Wolfe Research	Peer Perform → Outperform	$127
Jan-04-23	Upgrade	BofA Securities	Neutral → Buy	$110 → $130
Nov-18-22	Initiated	Credit Suisse	Outperform	$120

Show Previous Ratings

Feb-06-25 06:45AM	Merck Announces Phase 3 waveLINE-010 Trial Initiation Evaluating Zilovertamab Vedotin, an Investigational Antibody-Drug Conjugate, for the Treatment of Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (Business Wire)
05:07AM	With uncertainty roiling Big Pharma, execs are placing lower-risk bets (Pharma Voice)
Feb-05-25 05:10PM	Is Merck & Co. (MRK) the Best Dividend Stock to Buy and Hold? (Insider Monkey)
01:25PM	Analysts Defend Merck Amid Investor Concerns Over Weak Guidance (Benzinga)
08:45AM	Evaxion Biotech price target lowered to $6 from $35 at Lake Street (TipRanks)
08:06AM	Loading…
08:06AM	Why Merck & Co. Inc. (MRK) Went Down on Tuesday (Insider Monkey)
07:00AM	Merck Is Suffering From a Classic Pharma Problem (The Wall Street Journal)
06:39AM	Big Pharma is staying quiet on Trump's China tariffs (Quartz)
02:08AM	Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ... (GuruFocus.com)
01:31AM	Q4 2024 Merck & Co Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-04-25 04:14PM	Merck Stock Plummets 9% As Gardasil Dynamics, 2025 Guidance Weigh On Shares (Investor's Business Daily) -9.07%
03:15PM	Merck (MRK) Q4 2024 Earnings Call Transcript (Motley Fool)
03:01PM	Merck Stock Plunges 9.5% After China Halt--Is This the Beginning of Bigger Trouble? (GuruFocus.com)
02:38PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
12:40PM	Estée Lauder job cuts, Merck guidance, PepsiCo: Market Minute (Yahoo Finance Video)
12:36PM	Loading…
12:36PM	Pfizer, Merck Q4 earnings: A breakdown of the pharma stocks (Yahoo Finance Video)
12:28PM	Why Merck (MRK) Stock Is Falling Today (StockStory)
10:47AM	Merck sinks 10% as company halts Gardasil shipments to China, weighing on outlook (Investing.com)
10:38AM	Merck Shares Hit After Guidance Falls Short, Gardasil Challenge (The Wall Street Journal)
09:17AM	Merck 2025 sales forecast underwhelms as it pauses Gardasil sales in China (Associated Press Finance)
08:34AM	Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook (Benzinga)
08:21AM	Merck beats estimates on Q4 earnings, stock slides on tepid 2025 guidance (Yahoo Finance)
08:21AM	Merck beats estimates on fourth-quarter on earningsbut stock slides pre-market on tepid 2025 guidance (Yahoo Finance)
07:07AM	Merck shares tumble as company pauses Gardasil shipments to China (BioPharma Dive)
07:00AM	CIBC introduces additional Canadian Depositary Receipts ("CDRs") (PR Newswire)
06:54AM	Mercks (NYSE:MRK) Q4 Sales Top Estimates But Stock Drops (StockStory)
06:37AM	Merck: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Merck Tops Q4 Forecasts, But Dow Jones Giant Dives On 2025 Guidance (Investor's Business Daily)
06:30AM	Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results (Business Wire)
Feb-03-25 11:28AM	Jim Cramer on Merck & Co., Inc. (MRK): I Bet The Numbers Will Be Good, But There Are Other Issues (Insider Monkey)
04:13PM	Loading…
Feb-02-25 04:13PM	Is Merck & Co., Inc. (MRK) the Best Cancer Stock to Buy According to Hedge Funds? (Insider Monkey)
07:00AM	RFK Jr.s Financial Ties to Vaccine Lawsuits Hang Over Nomination (The Wall Street Journal)
Feb-01-25 04:44PM	Is Merck & Co. (MRK) the Best Dividend Stock on Robinhood? (Insider Monkey)
Jan-31-25 10:50AM	AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing (Yahoo Finance Video)
06:49AM	Novartis sets ambitious target; Skyrizi, Rinvoq sales climb (BioPharma Dive)
06:45AM	Merck Receives Positive EU CHMP Opinion for CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults (Business Wire)
Jan-30-25 12:45PM	Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things (Insider Monkey)
09:00AM	Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:45AM	Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR (sotatercept-csrk) Early and Move to Final Analysis (Business Wire)
Jan-29-25 04:24PM	Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100? (Insider Monkey)
08:04AM	Potential Revolution in Healthcare Brewing, Powered by AI Innovation (PR Newswire)
08:00AM	The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings (Investor's Business Daily)
06:58AM	Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy? (Insider Monkey)
Jan-28-25 01:28PM	Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization (Business Wire)
01:22PM	Is Merck & Co. (MRK) Among Kevin OLearys Stock Picks for 2025? (Insider Monkey)
10:00AM	Merck (MRK) Earnings Expected to Grow: Should You Buy? (Zacks)
Jan-27-25 03:07PM	Is Merck & Co. (MRK) the Best Depressed Stock to Invest in Now? (Insider Monkey)
06:45AM	FDA Grants Priority Review to Mercks Application for WELIREG (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL) (Business Wire)
Jan-25-25 01:18PM	Jim Cramer Says Merck & Co., Inc. (MRK) Needs To Have China Be Less Of Our Enemy (Insider Monkey)
10:58AM	Is Merck & Co., Inc. (MRK) the Best Dow Stocks to Buy Right Now? (Insider Monkey)
Jan-24-25 07:12AM	Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now? (Insider Monkey)
06:45AM	Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma (Business Wire)
06:17AM	Mixed results for Keytruda; AbbVie to work with Neomorph (BioPharma Dive)
Jan-22-25 07:10PM	Why Is Merck & Co., Inc. (MRK) Among the Best Large-Cap Value Stocks to Buy in 2025? (Insider Monkey)
04:46PM	Heres Why Merck & Co., Inc. (MRK) Is Among the Highest Yielding Dividend Stocks In the Dow (Insider Monkey)
04:34PM	Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines (Investor's Business Daily)
01:59PM	Is Merck & Co., Inc. (MRK) the Best Stock to Invest In For Steady Dividends? (Insider Monkey)
Jan-20-25 12:00PM	Why WEC Energy, Fifth Third Bancorp And Merck Are Winners For Passive Income (Benzinga)
07:37AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
Jan-19-25 06:15PM	Jim Cramer on Merck & Co., Inc. (MRK): Right Now, The Stocks Well-ensconced A Few Points Around 52-week Low (Insider Monkey)
Jan-18-25 05:08PM	Is Merck & Co., Inc. (MRK) the Best Cheap Stock to Buy for 2025? (Insider Monkey)
12:31PM	Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year (Yahoo Finance)
08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
Jan-17-25 04:13PM	Medicare to negotiate prices on 15 drugs, including Ozempic (Yahoo Finance Video)
09:46AM	Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations (Yahoo Finance)
09:00AM	Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Jan-16-25 06:45AM	Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4 (Business Wire)
Jan-15-25 12:37PM	Jim Cramer on Merck & Co., Inc. (MRK): Down Very Badly (Insider Monkey)
Jan-14-25 03:26PM	Jim Cramer Says Merck & Co., Inc. (MRK) Is Getting Pummeled (Insider Monkey)
01:04PM	JPM25: Amgens defense, Mercks patent hill and Vikings long-term planning (BioPharma Dive)
08:43AM	Merck Races to Launch Subcutaneous Keytruda Amid Looming Patent Expiry for IV Version (GuruFocus.com)
01:35AM	Merck is broadening its pipeline as Keytrudas patent cliff looms (Pharma Voice)
Jan-13-25 12:10PM	Is Merck & Co., Inc. (MRK) the Most Reliable Dividend Stock to Buy According to Hedge Funds? (Insider Monkey)
10:57AM	Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. (Investor's Business Daily)
Jan-10-25 04:56PM	Cramer on Merck & Co. (MRK): Trading Like a Value Trap Despite Strong Fundamentals (Insider Monkey)
02:12PM	Medicare drug prices nearly double, surpassing inflation: AARP (Yahoo Finance Video)
Jan-08-25 06:48AM	Mercks GARDASIL Receives Expanded Approval for Males in China (Business Wire)
Jan-07-25 01:36AM	WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million (The Wall Street Journal)
Jan-06-25 06:45AM	Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-02-25 11:15AM	UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal (Benzinga)
09:00AM	Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Jan-01-25 07:03AM	The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024 (TheStreet)
Dec-31-24 02:02PM	Is Merck & Co., Inc. (MRK) Among the Best Low Volatility Stocks to Buy Right Now? (Insider Monkey)
07:45AM	2 High-Yield Dividend Stocks to Buy Early in 2025 (Motley Fool)
Dec-30-24 05:32PM	Is Merck & Co., Inc. (MRK) the Best Pharma Dividend Stock to Buy In 2024? (Insider Monkey)
Dec-27-24 09:51AM	Merck & Co. Inc. (MRK): Billionaire D.E. Shaw Is Bullish On This Stock Right Now (Insider Monkey)
Dec-24-24 05:45PM	Merck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
12:20PM	3 biggest catalysts expected for healthcare in 2025 (Yahoo Finance Video)
Dec-21-24 07:30AM	Personalis price target raised to $8 from $7 at BTIG (TipRanks)
06:50AM	Merck closes exclusive global license agreement for LM-299 from LaNova Medicines (TipRanks)
Dec-20-24 09:44AM	BMO cuts rating on Merck and Biogen, on lack of near term catalyst (Investing.com)
09:00AM	Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:12AM	Is Merck & Co. (MRK) a Cheap NYSE Stock to Invest in Now? (Insider Monkey)
06:45AM	Merck Closes Exclusive Global License Agreement for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody (Business Wire)
Dec-19-24 01:39PM	Merck's Investigational Two-Drug Regime For HIV Meets Primary Goal In Two Late-Stage Trials (Benzinga)
10:00AM	A venture firm breathes new life into an old NGM drug (BioPharma Dive)
07:32AM	MSD makes obesity play in up to $2bn deal for Hansohs GLP-1RA asset (Pharmaceutical Technology)
06:45AM	Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for the Treatment of Adults with Virologically Suppressed HIV-1 Infection (Business Wire)
06:12AM	Why Is Merck & Co., Inc. (MRK) Among the Best Dividend Stocks to Invest In? (Insider Monkey)
03:00AM	Mercks RSV antibody could soon paddle into the rough waters of a crowded market (Pharma Voice)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
CRISTAL DOWNING	Officer	Feb 06 '25	Proposed Sale	88.76	2,361	209,551		Feb 06 04:43 PM
Guindo Chirfi	Chief Marketing Officer	Aug 05 '24	Option Exercise	115.20	36,901	4,250,995	57,782	Aug 06 12:20 PM
Smart Dalton	SVP Fin. - Global Controller	May 03 '24	Option Exercise	128.26	2,046	262,420	4,708	May 06 04:10 PM
Smart Dalton	SVP Fin. - Global Controller	May 04 '24	Option Exercise	127.51	612	78,036	4,730	May 06 04:10 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	May 04 '24	Option Exercise	127.51	27,126	3,458,836	163,720	May 06 04:08 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 04 '24	Option Exercise	127.51	887	113,101	24,058	May 06 04:06 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	May 04 '24	Option Exercise	127.51	912	116,289	24,271	May 06 04:01 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '24	Option Exercise	128.80	2,262	291,346	21,831	May 02 04:29 PM
Smart Dalton	SVP Fin. - Global Controller	May 02 '24	Option Exercise	128.80	381	49,073	3,048	May 02 04:23 PM
Merck & Co., Inc.	10% Owner	Mar 11 '24	Buy	23.00	21,397,205	492,135,715	1,000	Mar 11 03:27 PM
Litchfield Caroline	EVP & CFO	Feb 14 '24	Option Exercise	58.08	38,291	2,223,941	89,199	Feb 15 04:03 PM
Litchfield Caroline	EVP & CFO	Feb 14 '24	Sale	125.50	38,291	4,805,520	50,908	Feb 15 04:03 PM
Davis Robert M	Chairman, CEO & President	Feb 13 '24	Option Exercise	74.18	150,000	11,127,160	498,327	Feb 15 04:01 PM
Davis Robert M	Chairman, CEO & President	Feb 14 '24	Option Exercise	73.73	85,021	6,268,598	433,348	Feb 15 04:01 PM
Davis Robert M	Chairman, CEO & President	Feb 13 '24	Sale	125.85	150,000	18,877,424	348,327	Feb 15 04:01 PM
Davis Robert M	Chairman, CEO & President	Feb 14 '24	Sale	125.40	85,021	10,661,574	348,327	Feb 15 04:01 PM
Romanelli Joseph	President, Human Health Int?l	Feb 13 '24	Sale	124.89	1,000	124,888	19,569	Feb 14 04:03 PM
Li Dean Y	Executive VP & President, MRL	Feb 09 '24	Option Exercise	62.07	14,702	912,553	60,944	Feb 12 04:03 PM
Li Dean Y	Executive VP & President, MRL	Feb 09 '24	Sale	125.50	14,702	1,845,083	46,242	Feb 12 04:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRK

Merck & Co Inc

Upgrade your FINVIZ experience